Advenzymes
Live Price
Recent news and updates for ADVENZYMES will appear here soon.
"Caution advised for ADVENZYMES investors. AI signals correlate with a sustained bearish trend. Technical indicators suggest further consolidation within the basic materials sector before a reliable long-term bottom is established."
Verified by Stockmo Intelligence Grid
Citing cross-referenced internal documents and market technicals
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers serratiopeptidase, fungal lactase, peptizyme SP, nattokinase, fungal lipase, alpha galactosidase, saccharomyces boulardii, hemicellulose, papain, bromelain, fungal proteases, and bacterial alpha amylase. It also provides probiotics for human and animal nutrition. In addition, the company offers enzymes and probiotics for fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, oils and fats processing, biofuels, and specialty applications. Further, it provides non-food processing enzymes for textile, leather, and pulp and paper processing, as well as detergents and cleaning aids. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is based in Thane, India.
As of the latest market session, Advenzymes (ADVENZYMES) is trading at ₹263.55, representing a move of -0.23% from the previous close.
Advenzymes is listed and traded under the ticker symbol ADVENZYMES on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Advenzymes's stock price moved by -0.23%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Basic Materials industry.
Our proprietary AI Momentum engine calculates a 18% bullish probability for ADVENZYMES stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Advenzymes shares reached a high of ₹419 and hit a low of ₹246.8.
ADVENZYMES exhibits standard volatility for a Basic Materials stock, with an average daily trading volume of 1,81,291 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Advenzymes has a market capitalization of ₹2843.87 Cr, designating its size class inside the Basic Materials sector.
Advenzymes has a current dividend yield of 51.00%. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Advenzymes's trailing Price-to-Earnings (P/E) ratio is 18.10. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Advenzymes (ADVENZYMES) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Advenzymes's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore ADVENZYMES's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for ADVENZYMES are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Advenzymes operates inside the Basic Materials sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.